AIDOT Inc. – Trademark Portfolio
Entity Type: 03
AIDOT Inc. owns a portfolio of 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CERVIRAY, CONSCIOT, and SOLARDOT. Of these, 4 are registered and 8 are pending. The portfolio spans 6 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 11 (Environmental Control).
#C-1014, 128, Beobwon-ro,
Songpa-gu Seoul 05854
Showing of trademarks Trademarks
Trademark Classifications
AIDOT Inc.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Machines and machine tools; motors and engines; machine coupling and transmission components
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does AIDOT Inc. have?
AIDOT Inc. has 14 U.S. trademarks filed with the USPTO. Of these, 4 registered, 8 pending, 2 abandoned.
What trademark classes does AIDOT Inc. file in?
AIDOT Inc. files trademarks across 6 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 11 (Environmental Control), Class 8 (Hand Tools), Class 7 (Machinery), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are AIDOT Inc.'s most well-known trademarks?
AIDOT Inc.'s registered trademark portfolio includes well-known marks such as CERVIRAY, CONSCIOT, and SOLARDOT. These are among 4 currently registered trademarks in the portfolio.
What is AIDOT Inc.'s trademark registration success rate?
AIDOT Inc. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 8 applications are pending review.